Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

15 та иш

Иш: COVID-19 Response in Uzbekistan: From RT-PCR Test System to the Clinical Trial of Subunit Vaccine

  1. Correspondence - Tranexamic acid for traumatic brain injury

    Sasieni, Peter D; id_orcid 0000-0003-1509-8744, Duffy, Stephen W, Cuzick, Jack

    Мақола200511 иқтибос
    ABI

  2. Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan

    Mirzakamol S. Ayubov, Zabardast T. Buriev, Mukhammadjon K. Mirzakhmedov +5

    МақолаSARS-CoV-2 and COVID-19 ResearchPLoS ONE20229 иқтибос
    ABI

  3. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

    Lianpan Dai, Tianyi Zheng, Kun Xu +18

    Мақола20208 иқтибос
    ABI

  4. Сарлавҳасиз

    Бошқа8 иқтибос
    ABI

  5. A new coronavirus associated with human respiratory disease in China

    Fan Wu, Zhao Su, Bin Yu +16

    Мақола20208 иқтибос
    ABI

  6. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

    Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin +26

    Мақола20208 иқтибос
    ABI

  7. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

    Victor M. Corman, Olfert Landt, Marco Kaiser +21

    Мақола20207 иқтибос
    ABI

  8. Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults

    Lianpan Dai, Lidong Gao, Lifeng Tao +27

    Мақола20227 иқтибос
    ABI

  9. Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan

    А. А. Абдуллаев, Abrorjon Abdurakhimov, Zebinisa Mirakbarova +6

    МақолаSARS-CoV-2 and COVID-19 ResearchPLoS ONE20226 иқтибос
    ABI

  10. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

    Shilong Yang, Yan Li, Lianpan Dai +26

    Мақола20216 иқтибос
    ABI

  11. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

    Lindsey R. Baden, Hana M. El Sahly, Brandon Essink +34

    Мақола20206 иқтибос
    ABI

  12. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

    Jerald Sadoff, Glenda Gray, An Vandebosch +27

    Мақола20214 иқтибос
    ABI

  13. Challenges of COVID-19 testing in low-middle income countries (LMICs): the case of Malawi

    Steven Munharo, Symon Fidelis Nayupe, Patrick Mbulaje +6

    Мақола20202 иқтибос
    ABI

  14. Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future

    Fausto Baldanti, Nirmal Kumar Ganguly, Guiqiang Wang +6

    Шарҳ мақола20222 иқтибос
    ABI

  15. Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It

    Zhipeng Yan, Ming Yang, Ching‐Lung Lai

    Мақола20222 иқтибос
    ABI